<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>478(5)</volume><submitter>Mascolo M</submitter><funding>Università degli Studi di Napoli Federico II</funding><pubmed_abstract>Mycosis fungoides (MF) represents the most common type of cutaneous lymphoma. In the majority of patients, the disease has a slow evolution and a protracted course; however, a subset of patients shows poor oncologic outcomes. Unfortunately, there are no reliable prognostic markers for MF, and the currently available treatments are only effective in a minority of patients. This study aimed to evaluate the expression and clinical significance of PARP-1 and CAF-1/p60 in MF. Sixty-four MF representatives of the different stages of disease were assessed by immunohistochemistry for PARP-1 and CAF-1/p60. The association of PARP-1 and CAF-1/p60 with the MF stage and outcome was assessed by using Fisher's exact test and Kaplan-Meier survival analysis with the Log-rank test; a p value &lt; 0.05 was con</pubmed_abstract><journal>Virchows Archiv : an international journal of pathology</journal><pagination>961-968</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8099834</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides.</pubmed_title><pmcid>PMC8099834</pmcid><pubmed_authors>Russo D</pubmed_authors><pubmed_authors>Pane F</pubmed_authors><pubmed_authors>Varricchio S</pubmed_authors><pubmed_authors>Sabattini E</pubmed_authors><pubmed_authors>Travaglino A</pubmed_authors><pubmed_authors>Bertuzzi C</pubmed_authors><pubmed_authors>Pileri A</pubmed_authors><pubmed_authors>Agostinelli C</pubmed_authors><pubmed_authors>Mascolo M</pubmed_authors><pubmed_authors>Baldo A</pubmed_authors><pubmed_authors>Staibano S</pubmed_authors><pubmed_authors>Picardi M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides.</name><description>Mycosis fungoides (MF) represents the most common type of cutaneous lymphoma. In the majority of patients, the disease has a slow evolution and a protracted course; however, a subset of patients shows poor oncologic outcomes. Unfortunately, there are no reliable prognostic markers for MF, and the currently available treatments are only effective in a minority of patients. This study aimed to evaluate the expression and clinical significance of PARP-1 and CAF-1/p60 in MF. Sixty-four MF representatives of the different stages of disease were assessed by immunohistochemistry for PARP-1 and CAF-1/p60. The association of PARP-1 and CAF-1/p60 with the MF stage and outcome was assessed by using Fisher's exact test and Kaplan-Meier survival analysis with the Log-rank test; a p value &lt; 0.05 was con</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-18T13:17:19.858Z</modification><creation>2022-02-10T09:45:02.497Z</creation></dates><accession>S-EPMC8099834</accession><cross_references><pubmed>33098490</pubmed><doi>10.1007/s00428-020-02952-z</doi></cross_references></HashMap>